J. Sullivan-Bolyai

1.8k total citations · 1 hit paper
36 papers, 1.3k citations indexed

About

J. Sullivan-Bolyai is a scholar working on Infectious Diseases, Epidemiology and Hepatology. According to data from OpenAlex, J. Sullivan-Bolyai has authored 36 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 18 papers in Epidemiology and 11 papers in Hepatology. Recurrent topics in J. Sullivan-Bolyai's work include Herpesvirus Infections and Treatments (11 papers), HIV/AIDS drug development and treatment (10 papers) and Hepatitis C virus research (9 papers). J. Sullivan-Bolyai is often cited by papers focused on Herpesvirus Infections and Treatments (11 papers), HIV/AIDS drug development and treatment (10 papers) and Hepatitis C virus research (9 papers). J. Sullivan-Bolyai collaborates with scholars based in United States, Netherlands and Belgium. J. Sullivan-Bolyai's co-authors include Lawrence B. Schonberger, DONALD L. EDDINS, Dennis J. Bregman, Donald W. Ziegler, Richard A. Keenlyside, John A. Bryan, HENRY F. RETAILLIAU, Lawrence Corey, Harry F. Hull and Christopher Wilson and has published in prestigious journals such as JAMA, Neurology and PEDIATRICS.

In The Last Decade

J. Sullivan-Bolyai

36 papers receiving 1.2k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GUILLAIN-BARRE SYNDROME FOLLOWING VACCINATION IN THE NATIONAL INFLUENZA IMMUNIZATION PROGRAM, UNITED STATES, 1976–19771

1979 571 citations Lawrence B. Schonberger, Dennis J. Bregman et al. American Journal of Epidemiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Sullivan-Bolyai United States	16	614	532	333	157	149	36	1.3k
DONALD L. EDDINS United States	15	554 0.9×	409 0.8×	312 0.9×	132 0.8×	25 0.2×	19	1.1k
E Goddard South Africa	15	212 0.3×	221 0.4×	138 0.4×	54 0.3×	72 0.5×	51	974
Donald W. Ziegler United States	13	318 0.5×	298 0.6×	301 0.9×	133 0.8×	14 0.1×	28	872
Jantjie Taljaard South Africa	19	572 0.9×	460 0.9×	51 0.2×	46 0.3×	177 1.2×	83	1.2k
Brigitte Keller‐Stanislawski Germany	22	372 0.6×	317 0.6×	61 0.2×	29 0.2×	147 1.0×	91	1.6k
HENRY F. RETAILLIAU United States	7	280 0.5×	277 0.5×	303 0.9×	131 0.8×	11 0.1×	9	792
Yang Han China	23	376 0.6×	1.2k 2.3×	258 0.8×	28 0.2×	160 1.1×	104	1.8k
Marc Rivière Canada	10	386 0.6×	97 0.2×	149 0.4×	24 0.2×	121 0.8×	15	1.1k
Bruno Granwehr United States	17	309 0.5×	475 0.9×	32 0.1×	21 0.1×	75 0.5×	51	1.1k
Adam M. Spivak United States	23	414 0.7×	1.1k 2.0×	280 0.8×	176 1.1×	34 0.2×	62	2.5k

Countries citing papers authored by J. Sullivan-Bolyai

Since Specialization

Citations

This map shows the geographic impact of J. Sullivan-Bolyai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Sullivan-Bolyai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Sullivan-Bolyai more than expected).

Fields of papers citing papers by J. Sullivan-Bolyai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Sullivan-Bolyai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Sullivan-Bolyai. The network helps show where J. Sullivan-Bolyai may publish in the future.

Co-authorship network of co-authors of J. Sullivan-Bolyai

This figure shows the co-authorship network connecting the top 25 collaborators of J. Sullivan-Bolyai. A scholar is included among the top collaborators of J. Sullivan-Bolyai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Sullivan-Bolyai. J. Sullivan-Bolyai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ejemel, Monir, Thomas A. Smith, L. Greenberg, et al.. (2022). A cocktail of human monoclonal antibodies broadly neutralizes North American rabies virus variants as a promising candidate for rabies post-exposure prophylaxis. Scientific Reports. 12(1). 9403–9403. 12 indexed citations

Vince, Bradley, John M. Hill, Eric Lawitz, et al.. (2014). A randomized, double-blind, multiple-dose study of the pan-genotypic NS5A inhibitor samatasvir in patients infected with hepatitis C virus genotype 1, 2, 3 or 4. Journal of Hepatology. 60(5). 920–927. 19 indexed citations

Lalezari, Jacob, Terry Box, William O’Riordan, et al.. (2013). Idx184 in Combination with Pegylated Interferon-α2A and Ribavirin for 2 Weeks in Treatment-Naive Patients with Chronic Hepatitis C. Antiviral Therapy. 18(6). 755–764. 9 indexed citations

Bruijne, Joep de, André van Vliet, Christine J. Weegink, et al.. (2012). Rapid Decline of Viral RNA in Chronic Hepatitis C Patients Treated Once Daily with IDX320: A Novel Macrocyclic HCV Protease Inhibitor. Antiviral Therapy. 17(4). 633–642. 5 indexed citations

Lalezari, Jacob, David M. Asmuth, Hugo E. Vargas, et al.. (2012). Short-Term Monotherapy with IDX184, a Liver-Targeted Nucleotide Polymerase Inhibitor, in Patients with Chronic Hepatitis C Virus Infection. Antimicrobial Agents and Chemotherapy. 56(12). 6372–6378. 11 indexed citations

Zhou, Xiao‐Jian, Keith Pietropaolo, Jie Chen, et al.. (2010). Safety and Pharmacokinetics of IDX184, a Liver-Targeted Nucleotide Polymerase Inhibitor of Hepatitis C Virus, in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 55(1). 76–81. 50 indexed citations

Lalezari, Jacob, F. Poordad, P. Mehra, et al.. (2010). 2013 ANTIVIRAL ACTIVITY, PHARMACOKINETICS AND SAFETY OF IDX184 IN COMBINATION WITH PEGYLATED INTERFERON (PEGIFN) AND RIBAVIRIN (RBV) IN TREATMENT-NAIVE HCV GENOTYPE 1-INFECTED SUBJECTS. Journal of Hepatology. 52. S469–S469. 18 indexed citations

Pietropaolo, Keith, J. Sullivan-Bolyai, Bernice Kuca, et al.. (2009). 966 IDX184, A LIVER-TARGETED NUCLEOTIDE HCV POLYMERASE INHIBITOR: RESULTS OF A FIRST-IN-MAN SAFETY AND PHARMACOKINETIC STUDY. Journal of Hepatology. 50. S351–S351. 10 indexed citations

Xu, Chunhai, et al.. (2006). 36 Pharmacokinetics and pharmacodynamics of pradefovir, a liver-targeting prodrug of PMEA in HBV patients. Journal of Hepatology. 44. S16–S16. 4 indexed citations

10.

Rodvold, Keith A., et al.. (1993). Pharmacokinetics of intravenous vancomycin in pediatric cardiopulmonary bypass surgery. The Pediatric Infectious Disease Journal. 12(4). 300–303. 18 indexed citations

11.

Nelson, Kenrad E. & J. Sullivan-Bolyai. (1987). Preventing teratogenic viral infections in hospital employees: the cases of rubella, cytomegalovirus and varicella-zoster virus.. PubMed. 2(3). 471–98. 1 indexed citations

12.

Sullivan-Bolyai, J., et al.. (1987). Impact of chickenpox on households of healthy children. The Pediatric Infectious Disease Journal. 6(1). 33–35. 26 indexed citations

13.

Kaslow, Richard A., J. Sullivan-Bolyai, Robert C. Holman, et al.. (1987). Risk factors for Guillain‐Barre syndrome. Neurology. 37(4). 685–685. 5 indexed citations

14.

Sullivan-Bolyai, J., Harry F. Hull, Christopher Wilson, Arnold L. Smith, & Lawrence Corey. (1986). Presentation of neonatal herpes simplex virus infections. The Pediatric Infectious Disease Journal. 5(3). 309–314. 51 indexed citations

15.

Muench, Robin D., et al.. (1986). Seroepidemiology of Varicella. The Journal of Infectious Diseases. 153(1). 153–155. 36 indexed citations

16.

Sullivan-Bolyai, J.. (1983). Neonatal Herpes Simplex Virus Infection in King County, Washington. JAMA. 250(22). 3059–3059. 53 indexed citations

17.

Sullivan-Bolyai, J., Harry F. Hull, Christopher Wilson, & Lawrence Corey. (1983). Neonatal herpes simplex virus infection in King County, Washington. Increasing incidence and epidemiologic correlates.. PubMed. 250(22). 3059–62. 97 indexed citations

18.

Sullivan-Bolyai, J., David Nelson, David M. Morens, et al.. (1980). Reye Syndrome in Children Less than 1 Year Old: Some Epidemiologic Observations. PEDIATRICS. 65(3). 627–629. 6 indexed citations

19.

Sullivan-Bolyai, J., et al.. (1979). Hyperpyrexia due to air-conditioning failure in a nursing home.. PubMed. 94(5). 466–70. 9 indexed citations

20.

Schonberger, Lawrence B., Dennis J. Bregman, J. Sullivan-Bolyai, et al.. (1979). GUILLAIN-BARRE SYNDROME FOLLOWING VACCINATION IN THE NATIONAL INFLUENZA IMMUNIZATION PROGRAM, UNITED STATES, 1976–19771. American Journal of Epidemiology. 110(2). 105–123. 571 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact